Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health

Elizabeth O'Day, Leticia Hosta-Rigau, Diego A. Oyarzún, Hideyuki Okano, Víctor de Lorenzo, Conrad von Kameke, Habiba Alsafar, Cong Cao, Guo Qiang Chen, Weizhi Ji, Richard J. Roberts, Mostafa Ronaghi, Karen Yeung, Feng Zhang, Sang Yup Lee

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Patient X: A 67-year-old Caucasian man slips on a patch of ice. He has abrasions to his hands and has sustained significant damage to his hip. At the emergency room, he informs clinicians he takes atorvastatin, metformin, and glimepiride to treat hypertension and Type 2 Diabetes Mellitus (T2DM). X-rays reveal a fractured hip, which will require total hip replacement surgery.

Original languageEnglish
Article number1800195
JournalBiotechnology Journal
Volume14
Issue number1
DOIs
Publication statusPublished - 2019 Jan

    Fingerprint

Keywords

  • biotechnology
  • gene editing
  • precision medicine
  • stem cells
  • tissue engineering

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Molecular Medicine

Cite this

O'Day, E., Hosta-Rigau, L., Oyarzún, D. A., Okano, H., de Lorenzo, V., von Kameke, C., Alsafar, H., Cao, C., Chen, G. Q., Ji, W., Roberts, R. J., Ronaghi, M., Yeung, K., Zhang, F., & Lee, S. Y. (2019). Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health. Biotechnology Journal, 14(1), [1800195]. https://doi.org/10.1002/biot.201800195